PLEASANTON, Calif., Jan. 21, 2011 /PRNewswire/ — Thoratec
Corporation (Nasdaq:
THOR), a world leader in device-based mechanical circulatory
support therapies to save, support and restore failing hearts,
today announced that it will report its operating results for
fiscal year 2010 on Thursday, January 27.
The company will hold a conference call to discuss its financial
results and operating activities open to all interested parties at
1:30 p.m., Pacific Standard Time (4:30 p.m., Eastern Standard
Time), Thursday, January 27, hosted by Gary F. Burbach, president
and chief executive officer, and David V. Smith, executive vice
president and chief financial officer.
The teleconference can be accessed by calling (719) 457-2728,
passcode 5849363. Please dial in 10-15 minutes prior to the
beginning of the call. The webcast will be available on the
Internet at
http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=3661103
or at http://www.thoratec.com.
A replay of the conference call will be available through
Thursday, February 3, via http://www.thoratec.com or by
telephone at (719) 457-0820, passcode 5849363.
Thoratec is a world leader in therapies to address
advanced-stage heart failure. The company’s products include the
HeartMate® LVAS (Left Ventricular Assist System) and
Thoratec® VAD (Ventricular Assist Device) with more than 15,000
devices implanted in patients suffering from heart failure.
Thoratec is headquartered in Pleasanton, California. For more
information, visit the company’s web site at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate and HeartMate II are
registere
‘/>”/>
